Need help finding what you are looking for?
Contact Us
PUBLISHER: GlobalData | PRODUCT CODE: 1885510
PUBLISHER: GlobalData | PRODUCT CODE: 1885510
United States Cardiac Rhythm Management Devices Market Outlook to 2033 - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers
PUBLISHED:
PAGES: 51 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
GlobalData's "United States Cardiac Rhythm Management Devices Market Outlook to 2033" is a comprehensive databook report, covering key market data on the United States Cardiac Rhythm Management Devices market. The databook report provides value (USD), volume (units) and average prices (USD) within market segments - Cardiac Resynchronisation Therapy (CRT), Implantable Cardioverter Defibrillators (ICD) and Pacemakers
The United States Cardiac Rhythm Management Devices Market report provides key information and data on -
- Annualized market revenues (USD), volume (units) and average prices (USD) data for each of the market segments. Data is provided from 2018 to 2033.
- 2024 company share data for Cardiac Rhythm Management Devices Market.
- Global corporate-level profiles of key companies operating within the United States Cardiac Rhythm Management Devices Market. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is also available in the report.
Scope
United States Cardiac Rhythm Management Devices is segmented as follows -
- Cardiac Resynchronisation Therapy (CRT)
- Implantable Cardioverter Defibrillators (ICD)
- Pacemakers
Reasons to Buy
The United States Cardiac Rhythm Management Devices Market report helps you to develop -
- Business strategies by identifying the key market segments poised for strong growth in the future.
- Market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- Understand the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.
Product Code: GDME26199CCDB
Table of Contents
1 Table of Contents
- 1.1 List of Tables
- 1.2 List of Figures
2 Introduction
- 2.1 What Is This Report About?
- 2.2 Cardiac Rhythm Management Devices Market Segmentation
- 2.3 Definitions of Markets Covered in the Report
3 Cardiac Rhythm Management Devices Market, United States
- 3.1 Cardiac Rhythm Management Devices Market, United States, Revenue ($m), 2018-2033
- 3.1.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.1.3 Pacemakers Market, United States, Revenue ($m), by Segment, 2018-2033
- 3.2 Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2018-2033
- 3.2.1 Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.2 Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), by Segment, 2018-2033
- 3.2.3 Pacemakers Market, United States, Volume (Units), by Segment, 2018-2033
- 3.3 Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2018-2033
- 3.4 Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2024
4 Overview of Key Companies in United States, Cardiac Rhythm Management Devices Market
- 4.1 Medtronic Plc
- 4.1.1 Company Overview
- 4.2 Abbott Laboratories
- 4.2.1 Company Overview
- 4.3 Boston Scientific Corp
- 4.3.1 Company Overview
- 4.4 Biotronik SE & Co KG
- 4.4.1 Company Overview
- 4.5 MicroPort Scientific Corp
- 4.5.1 Company Overview
5 Cardiac Rhythm Management Devices Market Pipeline Products
6 Financial Deals Landscape
- 6.1 Equity Offerings
- 6.1.1 EBR Systems to Raise USD25.26 Million in Private Placement of Shares
- 6.1.2 EBR Systems Raises USD5.74 Million in Entitlement Offer of Shares
- 6.2 Partnerships
- 6.2.1 iRhythm Technologies Enters into Licensing Agreement with BioIntellisense
7 Recent Developments
- 7.1 Corporate Communications
- 7.1.1 Jul 08, 2025: Medtronic Appoints Chad Spooner as Chief Financial Officer of MiniMed
- 7.1.2 May 21, 2025: Medtronic Announces Leadership Change in Cardiovascular Portfolio
- 7.2 Financial Announcements
- 7.2.1 Jul 31, 2025: iRhythm Technologies Announces Second Quarter 2025 Financial Results
- 7.2.2 Apr 15, 2025: Orthofix to Report First Quarter 2025 Financial Results
- 7.2.3 Apr 07, 2025: CVRx Announces Preliminary Q1 2025 Results
- 7.2.4 Jan 28, 2025: Orthofix to Report Fourth Quarter and Full-Year 2024 Financial Results
- 7.2.5 Jan 21, 2025: CVRx to Report Fourth Quarter 2024 Financial and Operating Results and Host Conference Call on February 4, 2025
- 7.2.6 Nov 07, 2024: Orthofix Reports Third Quarter 2024 Results, Reiterates Full-Year 2024 Financial Guidance, and Introduces New Three-Year Financial Targets
- 7.2.7 Oct 23, 2024: Boston Scientific Reports Results for Q3 2024
- 7.2.8 Oct 10, 2024: Orthofix to Report Third Quarter 2024 Financial Results
- 7.2.9 Oct 02, 2024: Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
- 7.3 Government and Public Interest
- 7.3.1 Aug 20, 2025: iRhythm Technologies to Participate in Upcoming Investor Conferences
- 7.3.2 Jun 19, 2025: Mah Sing Healthcare Sdn Bhd Receives 510(K) Clearance For Nitrile Powder Free Examination Glove with Tremella Fuciformis Extract
- 7.3.3 Mar 03, 2025: Orthofix to Participate in the 37th Annual Roth Conference
- 7.3.4 Nov 12, 2024: Orthofix to Participate in Upcoming Investor Conferences
- 7.3.5 Oct 21, 2024: Orthofix to Participate in Stifel 2024 Healthcare Conference
- 7.4 Product News
- 7.4.1 Feb 03, 2025: Integer to Showcase Leadership in Medical Device Innovation and Recent Acquisition of Precision Coating at MD&M West 2025
- 7.4.2 Sep 26, 2024: Engineering Human Heart Tissue for Scientific Study
- 7.5 Strategy And Business Planning
- 7.5.1 Jan 28, 2025: EBR Leases New Facility to Expand Manufacturing Capabilities
8 Appendix
- 8.1 Research Methodology
- 8.1.1 Coverage
- 8.1.2 Secondary Research
- 8.1.3 Primary Research
- 8.1.4 Market Modeling and Forecasting
- 8.1.5 Company Share Analysis
- 8.1.6 Benchmarking
- 8.2 GlobalData Consulting
- 8.3 Contact Us
- 8.4 Disclaimer
Product Code: GDME26199CCDB
List of Table
List of Tables
- Table 1: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 2: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 3: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 4: Pacemakers Market, United States, Revenue ($m), USD Constant, 2018-2033
- Table 5: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2018-2033
- Table 6: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2018-2033
- Table 7: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2018-2033
- Table 8: Pacemakers Market, United States, Volume (Units), 2018-2033
- Table 9: Cardiac Rhythm Management Devices Market, United States, Average Price ($), 2018-2033
- Table 10: Cardiac Rhythm Management Devices Market, United States, Company Share by Revenue ($m), 2024
- Table 11: Cardiac Rhythm Management Devices Market Pipeline Products
- Table 12: EBR Systems to Raise USD25.26 Million in Private Placement of Shares
- Table 13: EBR Systems Raises USD5.74 Million in Entitlement Offer of Shares
- Table 14: iRhythm Technologies Enters into Licensing Agreement with BioIntellisense
- Table 15: Total Number of Primary Research Participants, Cardiovascular devices Market, by Country
List of Figure
List of Figures
- Figure 1: Cardiac Rhythm Management Devices Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 2: Cardiac Resynchronisation Therapy (CRT) Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 3: Implantable Cardioverter Defibrillators (ICD) Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 4: Pacemakers Market, United States, Revenue ($m), USD Constant, 2018-2033
- Figure 5: Cardiac Rhythm Management Devices Market, United States, Volume (Units), 2018-2033
- Figure 6: Cardiac Resynchronisation Therapy (CRT) Market, United States, Volume (Units), 2018-2033
- Figure 7: Implantable Cardioverter Defibrillators (ICD) Market, United States, Volume (Units), 2018-2033
- Figure 8: Pacemakers Market, United States, Volume (Units), 2018-2033
- Figure 9: Cardiac Rhythm Management Devices Market, United States, Company Share (%), 2024
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.